AIDS Weekly

HIV/AIDS - Studies in the area of HIV/AIDS reported from Ecole normale superieure

HIV/AIDS Animal Studies - Study results from Pennsylvania State University update understanding of HIV/AIDS animal studies

HIV/AIDS Immunology - New HIV/AIDS immunology study results reported from Swedish Institute for Infectious Disease Control

HIV/AIDS Risk Factors - Research from University Medical Center in the area of HIV/AIDS risk factors published

HIV/AIDS Risk Factors - Research reports on HIV/AIDS risk factors from University of California, Semel Institute for Neuroscience provide new insights

HIV/AIDS Risk Factors - Researchers at University of Connecticut, Health Center target HIV/AIDS risk factors

HIV/AIDS Therapy - New HIV/AIDS therapy data have been reported by scientists at New York University, University Cancer Institute

HIV/AIDS Therapy - New HIV/AIDS therapy research has been reported by scientists at University of Texas, Department of Internal Medicine

HIV/AIDS Therapy - Research on HIV/AIDS therapy discussed by scientists at University of Cordoba

HIV/AIDS Therapy - Studies from Pasteur Institute of Iran, Research Department provide new data on HIV/AIDS therapy

HIV/AIDS Vaccines - Data on HIV/AIDS vaccines described by researchers at Swedish Institute for Infectious Disease Control, Department of Virology

HIV/AIDS Vaccines - Data on HIV/AIDS vaccines published by researchers at Karolinska Institut

HIV/AIDS Vaccines - Data on HIV/AIDS vaccines reported by investigators at Research Institute for Genetic and Human Therapy

HIV/AIDS Vaccines - New findings reported from Linkoping University, Department of Molecular Virology describe advances in HIV/AIDS vaccines

HIV/AIDS Vaccines - Research on HIV/AIDS vaccines reported by scientists at Karolinska Institute

HIV/AIDS Vaccines - Researchers from Institute of Microbiology detail findings in HIV/AIDS vaccines

HIV/AIDS Vaccines - Scientists at Engelhardt Institute of Molecular Biology report research in HIV/AIDS vaccines

HIV/AIDS Vaccines - Scientists at Wyeth publish research in HIV/AIDS vaccines

HIV/AIDS Vaccines - Studies in the area of HIV/AIDS vaccines reported from Dartmouth University, Department of Microbiology & Immunology

Immunization - Scientists at Center for Cancer Research detail research in immunization

Life Sciences - Research from University of Alabama provide new insights into life sciences

Life Sciences - Study findings from University of Texas, Department of Internal Medicine broaden understanding of life sciences

Lymphoma Cell Biology - Medical College of Georgia, Department of Pathology reports research in lymphoma cell biology

Abyssinian Development Corporation - Former President Bill Clinton and Abyssinian Development Corporation Honor Reverend Dr. Calvin O. Butts, III at a Star-Studded White Tie Gala

AIDS Healthcare Foundation - AHF'S AIDS Drug-Pricing Campaign Arrives in Abbott Executives' Home Mailboxes

Ardea Biosciences, Inc. - Ardea Biosciences Presents Additional Phase 2a and Preclinical Data on its Lead HIV Product Candidate, RDEA806, at the 48th Annual ICAAC/IDSA 46th Annual Meeting

Ardea Biosciences, Inc. - Ardea Biosciences Presents Preliminary Data from a Phase 1 Study of RDEA594 at the 2008 ACR/ARHP Annual Scientific Meeting

Argos Therapeutics - Argos Therapeutics Publishes Novel Approach to Improving Stimulation of Immunotherapeutic Pathways via Dendritic Cells

Georgetown University Medical Center - GUMC researchers hone in on new strategy to treat common infection

Gilead Sciences, Inc. - Gilead Announces Two-Year Clinical Data for Letairis ambrisentan for the Treatment of Pulmonary Arterial Hypertension WHO Group 1

Henry Ford Health System - Rapid HIV testing in the ER boosts diagnoses, screening

HIV/AIDS - 96-Week Data From CASTLE Study Continue to Show Similar Efficacy Between Once-Daily REYATAZ® (atazanavir sulfate)/Ritonavir and Twice-Daily Lopinavir/Ritonavir In Previously Untreated

HIV/AIDS - Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients

HIV/AIDS - Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay

HIV/AIDS - EMD Serono and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States

HIV/AIDS - House Candidates Jim Himes and Chris Shays Pledge Action on HIV/AIDS Epidemic

HIV/AIDS - Local Organization Receives Multi-Million Dollar Grants for Natural Family Planning, HIV Testing and Family Planning Services for Men

HIV/AIDS - Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults

HIV/AIDS - Monogram Announces 2008 Third Quarter Financial Results

HIV/AIDS - Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic

HIV/AIDS - Senator Dean Barkley Pledges Action on HIV/AIDS Epidemic

HIV/AIDS - Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor

HIV/AIDS - Why Are Some Veterans Who Are Coinfected With Hepatitis C and HIV More Likely to Be Treated for HCV Than Others?

HIV/AIDS Co-Infection - Land O'Lakes Collaborates With Ethiopian Farmers to Create Livelihoods for People Living With HIV/AIDS

HIV/AIDS Co-Infection - Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing 'Tuskegee Effect' When Recruiting Minorities for Research Studies

Merck & Co., Inc. - New Phase III Study in Previously Untreated HIV Patients Showed Merck's ISENTRESS raltegravir Reduced HIV Viral Load to Undetectable Levels, Comparable to Efavirenz, When Taken in Combination with Other Medicines

NewsRx - NewsRx Launches Politics & Government Titles; Offers Free Global Warming Publication

NIH/National Institute of Allergy and Infectious Diseases - Study suggests HIV-infected patients should start HAART sooner

OraSure Technologies, Inc. - OraSure Technologies Files for FDA Approval of OraQuick Rapid Hepatitis C Test

Panacos Pharmaceuticals, Inc. - Panacos Announces Preliminary Results of Bevirimat Study 204

Pfizer Inc - Pfizer's Novel HIV/AIDS Treatment Selzentry Maraviroc Demonstrates Increased Efficacy Rate In Treatment-Naive HIV Patients

Pop!Tech - Pop!Tech Unveils Project Masiluleke: Largest-Ever Use of Mobile Devices for Delivery of HIV/AIDS & TB Care

Progenics Pharmaceuticals, Inc. - Progenics Reports Positive Interim Phase 2 Results for Two Dosage Forms of Novel HIV Therapy PRO 140

Revolutions Medical Corporation - Revolutions Medical Corporation Files Pre Market 510K Application with the FDA for 3cc Rev Vac Safety Syringe

Roche Molecular Diagnostics - Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform

Targanta Therapeutics Corporation - Targanta Presents Efficacy and Safety Data for Oritavancin for the Treatment of Gram-Positive Complicated Skin and Skin Structure Infections cSSSI

University of California - Los Angeles - UCLA develops safer, more effective TB vaccine for HIV-positive people